These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9060675)

  • 41. Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals.
    Lucchiari-Hartz M; Bauer M; Niedermann G; Maier B; Meyerhans A; Elchmann K
    Int Immunol; 1996 Apr; 8(4):577-84. PubMed ID: 8671645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8+ T lymphocytes.
    Ohashi T; Kubo M; Kato H; Iwamoto A; Takahashi H; Fujii M; Kannagi M
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():209-216. PubMed ID: 9934704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.
    Wang B; Dyer WB; Zaunders JJ; Mikhail M; Sullivan JS; Williams L; Haddad DN; Harris G; Holt JA; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK
    Virology; 2002 Dec; 304(2):246-64. PubMed ID: 12504566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones.
    Kurane I; West K; Tuazon CU; Zeng W; Ennis FA
    J Clin Virol; 2003 May; 27(1):38-43. PubMed ID: 12727527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
    Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTL recognition of HIV-1-infected cells via cross-recognition of multiple overlapping peptides from a single 11-mer Pol sequence.
    Hashimoto M; Akahoshi T; Murakoshi H; Ishizuka N; Oka S; Takiguchi M
    Eur J Immunol; 2012 Oct; 42(10):2621-31. PubMed ID: 22740036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
    Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
    AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
    Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A
    J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-class I-specific inhibitory receptors in HIV-1 infection.
    De Maria A; Moretta L
    Hum Immunol; 2000 Jan; 61(1):74-81. PubMed ID: 10658980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine.
    Singh RA; Wu L; Barry MA
    J Immunol; 2002 Jan; 168(1):379-91. PubMed ID: 11751984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 60. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.